Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies → EURORDIS - RARE DISEASES EUROPE

Originally published in French

High language barrierEnglish translation available ↓

Opportunity overview

Recipient: EURORDIS - RARE DISEASES EUROPE • Role: participant • EC contribution: €736,895 • Project: SCREEN4CARE • Objective: In the EU alone, according to the Orphanet DB (https://pubmed.ncbi.nlm.nih.gov/31527858/), 30 million persons, 3,5-6% of the general population, are affe

Pro Feature

Unlock Complete Call Dossier

Read the unredacted funding guidelines, scope, eligibility criteria, and submission instructions.

Upgrade to Pro to Read Full Call →

EU Fund Portal Signals

Is this worth the team's time?

Directional signals based on the call structure, available source text, and deadline pressure. These are not funding guarantees.

Source language: FrenchConfidence: Medium

Competition

4/ 5

Lower Competition

5 means a narrower, more approachable field. 1 means heavy competition.

Application Effort

1/ 5

Very Simple

1 is straightforward. 5 means a demanding application with heavier coordination or compliance.

Why competition looks like this

Confidence: Medium

The call looks specialized, which can narrow the field of credible applicants.
TRL requirements and cross-border consortium specifications restrict eligible applicant pools.
Budget allocations indicate high proposal success probabilities for specialised applicants.

Why effort looks like this

Confidence: Low

Built from the available grant metadata and call structure.
Submission dossier requires multi-partner budget synchronization and work package signoffs.
Administrative guidelines impose formal SME compliance declarations and financial audits.

AI Dossier Preview

Unlock Full Feasibility Intelligence & Consultant Analysis

Pro members access complete competitive breakdowns, compliance risk analyses, plain-English translations for foreign-language notices, and tailored submission checklists.

Unlock Pro Intelligence →Instant access • Cancel anytime

Consortium

Probably not required

Co-funding

Not clearly indicated

Documentation

Low

Deadline pressure

Closed

Eligibility scope

Narrow

Technical depth

Low

Plain-English translation

The original call appears to be in French. Translate the source summary and eligibility notes into concise English for faster review.

Translate with Pro Trial →

Eligibility

Awarded

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies → EURORDIS - RARE DISEASES EUROPE

Opportunity overview

Unlock Complete Call Dossier

Is this worth the team's time?

Why competition looks like this

Why effort looks like this

Unlock Full Feasibility Intelligence & Consultant Analysis

Plain-English translation

Eligibility

Application deadline

Key information

Official Application Portal

Preparation Checklist